OA10.05 Phase I Trial of DLL3/CD3 IgG-Like T-Cell Engager BI 764532 in Patients with DLL3-Positive Tumors: Patients with LCNEC

Autor: Wermke, M., Gambardella, V., Kuboki, Y., Alese, O.B., Morgensztern, D., Sayehli, C., Sanmamed, M.F., Arriola, E., Wolf, J., Villaruz, L., Studeny, M., Bouzaggou, M., Fang, X., Felip, E.
Zdroj: In Journal of Thoracic Oncology October 2024 19(10) Supplement:S32-S32
Databáze: ScienceDirect